DTaP-IPV/Hib

DTaP-IPV/Hib is a combined vaccine used to prevent diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (Hib). It is given by injection into a muscle.

Composition

The DTaP-IPV/Hib vaccine contains the following components:

• Diphtheria toxoid: This is a modified version of the toxin produced by the bacterium Corynebacterium diphtheriae. It stimulates the immune system to produce antibodies against the diphtheria toxin.
• Tetanus toxoid: This is a modified version of the toxin produced by the bacterium Clostridium tetani. It stimulates the immune system to produce antibodies against the tetanus toxin.
• Acellular pertussis vaccine: This contains purified components of the bacterium Bordetella pertussis, which causes whooping cough. It stimulates the immune system to produce antibodies against these components.
• Inactivated poliovirus vaccine: This contains inactivated (killed) polioviruses of all three types. It stimulates the immune system to produce antibodies against the polioviruses.
• Haemophilus influenzae type b vaccine: This contains a component of the bacterium Haemophilus influenzae type b. It stimulates the immune system to produce antibodies against this bacterium.

Usage

The DTaP-IPV/Hib vaccine is typically given in a series of shots, starting at two months of age. The usual schedule is at two, four, and six months of age, with a booster dose given between 15 and 18 months of age. Another booster is given before starting school, at four to six years of age.

Side effects

Common side effects include pain at the injection site, fever, and irritability. Serious side effects are rare but can include severe allergic reactions.

See also

• Vaccine
• Immunization schedule
• Diphtheria
• Tetanus
• Pertussis
• Polio
• Haemophilus influenzae type b

DTaP-IPV/Hib Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski